Verge Genomics - Tech Innovator Profile

Verge Genomics - Tech Innovator Profile

Summary

Founded in 2015, Verge Genomics is an AI-driven biopharmaceutical drug discovery company that applies patient genomes, epigenomics, and gene expression for identifying novel effective drugs; stratify patient subpopulations, and therapeutic gene targets for accelerating clinical success. Verge Genomics is focusing on three neurodegenerative diseases: frontotemporal dementia (FTD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS).

Scope

The report provides information and insights into Verge Genomics, including -

• Overview of the company and its product offering
• Detailed insight into its business model, company type and headquarter
• Information on funding and partnership
• Biography of top management

• Gain insights into Verge Genomics' business operations.
• Gain insights into partnership and funding.
• Gain understanding about its technology focus.